SYMPOSIUM
pscmanual/17pscnosinfdef_current.pdf. Accessed July 7, 2016.
16. Zimlichman E,Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial im- pact on the US health care system. JAMA Intern Med. 2013;173(22):2039–2046.
17. Saint S, Lipsky BA, Goold SD. Indwelling urinary catheters: a one-point restraint? Ann Intern Med. 2002;137(2):125–127.
18. Hollingsworth JM, Rogers MA, Krein SL, et al. Determining the noninfectious complications of indwelling urethral cath- eters: a systematic review and meta-anal- ysis. Ann Intern Med. 2013;159(6):401–410.
19. Lo E, Nicolle LE, Coffin SE, et al. Strat- egies to prevent catheter-associated uri- nary tract infections in acute care hos- pitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(5):464–479.
20. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Preven- tion. MMWR Recomm Rep. 2002;51:1–29.
21. Safdar N,Mermel LA,Maki DG. The epi- demiology of catheter-related infection in the critically ill. In: O’Grady N, Pittet D, eds. Catheter Related Infections in the Critically Ill. New York, NY: Kluwer; 2004:1–23.
22. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. Pathogenesis and short-term devices. Clin Infect Dis. 2002;34(9):1232– 1242.
23. Mermel LA, Allon M, Bouza E, et al. Clini- cal practice guidelines for the diagnosis and management of intravascular cathe- ter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.
24. O’Grady NP, Alexander M, Burns LA, et al;Healthcare Infection Control Practices Advisory Committee (HICPAC). Guide- lines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–e193.
25. Klompas M, Magill S, Robicsek A, et al. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med. 2012;40(12):3154–3161.
26. CDC/NHSN. Ventilator-associated event (VAE) surveillance for adults special edi- tion. Atlanta, GA: Centers for Disease Prevention and Control, NationalHealth- care SafetyNetwork; September 2012:1–6.
https://www.cdc.gov/nhsn/pdfs/newslet ters/vae-newsletter-september2012.pdf. Accessed July 7, 2016.
27. Klompas, M. Ventilator-associated events surveillance: a patient safety opportunity. Curr Opin Crit Care. 2016;19(5):424–431. 28. CDC/NHSN. Ventilator-associated event
(VAE) calculator (Version 3.0). Atlanta, GA: Centers for Disease Control and Pre- vention, National Healthcare Safety Net- work.
http://www.cdc.gov/nhsn/vae-cal culator/
index.html.Accessed July 11, 2016.
29. Boyer AF, Schoenberg N, Babcock H, McMullen KM, Micek ST, Kollef MH. A prospective evaluation of ventilator-as- sociated conditions and infection-related ventilator-associated conditions. Chest. 2015;147(1):68–81.
30. Klompas M, Branson R, Eichenwald EC, et al. Strategies to prevent ventilator-asso- ciated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epide- miol. 2014;35 Suppl 2:S133–S154.
31. Klompas M, Li L, Kleinman K, Szu- mita PM, Massaro AF. Associations be- tween ventilator bundle compenents and outcomes. JAMA Intern Med. 2016. 2016;176(9):1277–1283.
32. Klompas, M. Potential strategies to pre- vent ventilator-associated events. Am J Respir Crit Care Med. 2015;192(12):1420– 1430.
33. Osmon DR, Berbari EF, Berendt AR, et al; Infectious Diseases Society of America. Executive summary: diagnosis and man- agement of prosthetic joint infection: clin- ical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):1–10.
34. Centers forMedicare &Medicaid Servic- es. Comprehensive care for joint replace- ment model.
https://innovation.cms.gov/ initiatives/cjr. Accessed July 7, 2016.
35. Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infec- tions in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S51–S61.
36. National Guideline Clearinghouse. Surgi- cal site infection: prevention and treat- ment of surgical site infection. Agency for Healthcare Research and Quality. http://
www.guideline.gov/content.aspx?id=1341 6&search=surgical+site+infection+preven tion. Accessed July 12, 2016.
37. Centers for Diseases Control and Preven- tion. Antibiotic Resistance Threats in the United States, 2016. Atlanta, GA: Cen- ters for Disease Control and Prevention; 2016:54.
http://www.cdc.gov/drugresis tance/pdf/ar-threats-2013-508.pdf. Ac- cessed July 7, 2016.
38. Lessa FC, Winston LG, McDonald LC; Emerging Infections Program C. difficile SurveillanceTeam. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834.
39. Bignardi GE. Risk factors for Clostrid- ium difficile infection. J Hosp Infect. 1998;40(1):1–15.
40. Huang SS, Datta R, Platt R. Risk of ac- quiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med.
2006;166(18):1945–1951.
41. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room as- signment and acquisition of Clostridium difficile infection. Infect Control Hosp Epi- demiol. 2011;32(3):201–206.
42. Han JH, Sullivan N, Leas BF, Pegues DA, Kaczmarek JL, Umscheid CA. Cleaning hospital room surfaces to prevent health care-associated infections: a technical brief. Ann Intern Med. 2015;163(8):598– 607.
43. Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.
44. Huslage K, RutalaWA, Sickbert-Bennett E,Weber DJ. A quantitative approach to defining “high-touch” surfaces in hos- pitals. Infect Control Hosp Epidemiol. 2010;31(8):850–853.
45. Rutala WA, Weber DJ. Are room de- contamination units needed to prevent transmission of environmental patho- gens? Infect Control Hosp Epidemiol. 2011;32(8):743–747.
46. Jinadatha C, Villamaria FC, Ganachari- Mallappa N, et al. Can pulsed xenon ultra- violet light systems disinfect aerobic bac- teria in the absence of manual disinfec- tion? Am J Infect Control. 2015;43(4):415– 417.
47. Rutala WA, Gergen MF, Weber DJ. Room decontamination with UV ra- diation. Infect Control Hosp Epidemiol. 2010;31(10):1025–1029.
48. Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of ter- minal room cleaning with bleach on re- ducing nosocomial Clostridium difficile. Am J Infect Control. 2010;38(5):350–353.
49. Monk AB, Kanmukhla V, Trinder K, BorkowG. Potent bactericidal efficacy of copper oxide impregnated non-porous solid surfaces. BMC Microbiol. 2014;14:57.
50. Noyce JO, Michels H, Keevil CW. Po- tential use of copper surfaces to re- duce survival of epidemic meticillin- resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect. 2006;63(3):289–297.
51. Karpanen TJ, Casey AL, Lambert PA, et al. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epi- demiol. 2012;33(1):3–9.
52. Weaver L, Michels HT, Keevil CW. Sur- vival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene.J Hosp Infect. 2008;68(2):145–151.
53. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol. 2011;77(5):1541–1547.
February 2017 TEXAS MEDICINE 47
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68